FDA Inspection 1059727 — Daniel L. Peterson, M.D.
The FDA completed an inspection of Daniel L. Peterson, M.D. on May 17, 2018 in Incline Village, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Incline Village, NV (United States)
Additional Details
Clinical Investigator (CI)